激光间质热疗在神经肿瘤中的定位:适应证、影像学与辅助治疗
本综述阐述激光间质热疗(LITT)在胶质瘤、复发性脑转移瘤和放射性坏死中的扩展适应证,包括邻近功能区、后颅窝、脑膜瘤和椎柱肿瘤;多数患者术后12-48小时内出院并可快速恢复全身和放疗;需建立LITT术后影像反应评估标准。
要点
- LITT在运动皮质、后颅窝和椎柱等部位的安全性证据持续积累,脑膜瘤等新病种也有应用。
- 无论组织学类型,多数患者LITT术后12-48小时内出院,可快速恢复全身和放射治疗。
- LITT不应妨碍后续临床试验入组,热疗调节血脑屏障通透性并可能与免疫治疗协同。
核心结论
- 随着LITT融入神经外科肿瘤实践,新用途将持续涌现;激光消融较开放切除缩短住院时间并减少功能障碍,亟需制定LITT治疗病灶的影像学反应评估标准,使患者更快接受确定性治疗或进入临床试验。
- LITT及辅助联合治疗的前瞻性评估正在进行中。
研究设计与样本
- 综述,检索范围未明确报告。
主要发现
- LITT在运动皮质、后颅窝和椎柱等不同部位以及脑膜瘤等新病种的安全性证据持续积累。
- 无论疾病组织学类型,多数患者LITT术后12-48小时内出院,可快速恢复全身和放射治疗。
- 新兴数据已允许对LITT术后影像学表现进行特征描述;接受LITT不应妨碍后续临床试验入组,尤其因为热疗调节血脑屏障通透性并可能与免疫治疗协同。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: There is an unmet need for new treatments for many central nervous system tumors. An expanding body of research supports the use of laser interstitial thermal therapy (LITT) in the treatment of gliomas, recurrent brain metastases, and radiation necrosis. METHODS: In this review, we highlight emerging indications for LITT, including its use adjacent to eloquent structures, in the posterior fossa, and for meningioma and tumors of the vertebral column. We conclude by providing an overview of current research into post-LITT response assessment and adjunctive therapies. RESULTS: Evidence has continued to accumulate regarding the safety of LITT in locations as varied as the motor cortex, posterior fossa, and vertebral column, as well as for novel pathologies such as meningioma. Regardless of disease histology, most patients leave the hospital within 12-48 h of LITT and can rapidly return to systemic and radiation therapies. Emerging data has allowed for a characterization of post-LITT imaging findings, and receipt of LITT should not preclude subsequent clinical trial enrollment, especially as hyperthermia modulates blood-brain barrier permeability and may synergize with immunotherapies. CONCLUSION: As LITT is incorporated into neurosurgical oncology practice, novel use cases will continue to emerge. Given that laser ablation is associated with shortened length of stay and decreased debility relative to open resection, development of radiographic response assessment criteria for LITT-treated lesions is urgently needed so that patients may more rapidly receive definitive management or proceed to clinical trial enrollment. Prospective evaluation of LITT and adjunctive combination therapies is ongoing.
引用
- Haskell-Mendoza AP, Gonzalez AT, Reason EH, et al. The LITT Fit in neuro-oncology: indications, imaging, and adjunctive therapies. J Neurooncol. 2024. PMID: 39585599. doi:10.1007/s11060-024-04894-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。